By stimulating the accumulation of PD‐L1 in exosomes, histone lysine‐specific demethylase 1 (LSD1) decreases the percentage of CD8+ T cells in the microenvironment of GC cells, making LSD1 a novel target for immunotherapy against GC.196. The gene discussed is KDM1A; the disease is gastric cancer.